drugset / Trial / NCT03407378
A Study to Investigate a New Treatment in Patients With Parkinson's Disease
RandomizedParallel-groupSingle-blindBasic science
Summary
The purpose of this clinical trial conducted in patients with Parkinson's Disease is to study the relationship between patient individual profile and their response to IPT803 Adjunct Treatment (treatment response being characterized by movements improvement).
Timeline
- Start
- 2018-06-26
- Primary completion
- 2020-02-07
- Completion
- 2020-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IPT803 | Unknown | — | — |